Search research articles
Contact Us
Filters
Showing results (1-10 of 131) with videos related to
Page
of 14
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2010
When reversible ligands do not reverse, and other modelers' dilemmas
Mark Slifstein
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 5, 2008
Revisiting an old issue: the discrepancy between tissue ratio-derived binding parameters and kinetic modeling-derived parameters after a bolus of the serotonin transporter radioligand 123I-ADAM
Mark Slifstein
Seminars in Nuclear Medicine
|
December 19, 2016
Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders
Mark Slifstein, Anissa Abi-Dargham
Biological Psychiatry
|
March 22, 2018
Is it Pre- or Postsynaptic? Imaging Striatal Dopamine Excess in Schizophrenia
Mark Slifstein, Anissa Abi-Dargham
Biological Psychiatry
|
May 31, 2023
Detecting Pharmacologically Induced Serotonin Release in Depression With Positron Emission Tomography Imaging: A New Approach
Mark Slifstein, Anissa Abi-Dargham
Methods (San Diego, Calif.)
|
August 17, 2002
Positron emission tomography: imaging and quantification of neurotransporter availability
Marc Laruelle, Mark Slifstein, Yiyun Huang
Molecular Imaging and Biology
|
December 12, 2003
Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography
Marc Laruelle, Mark Slifstein, Yiyun Huang
Handbook of Clinical Neurology
|
October 14, 2014
Molecular imaging in alcohol dependence
Shervin Ravan, Diana Martinez, Mark Slifstein, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 18, 2019
A positron emission tomography occupancy study of brexpiprazole at dopamine D<sub>2</sub> and D<sub>3</sub> and serotonin 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors, and serotonin reuptake transporters in subjects with schizophrenia
Ragy R Girgis, Andy Forbes, Anissa Abi-Dargham, et al.
International Review of Neurobiology
|
November 18, 2005
Neuroreceptor imaging in psychiatry: theory and applications
W Gordon Frankle, Mark Slifstein, Peter S Talbot, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 131) with videos related to
Sort By:
Page
of 14
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2010
When reversible ligands do not reverse, and other modelers' dilemmas
Mark Slifstein
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 5, 2008
Revisiting an old issue: the discrepancy between tissue ratio-derived binding parameters and kinetic modeling-derived parameters after a bolus of the serotonin transporter radioligand 123I-ADAM
Mark Slifstein
Seminars in Nuclear Medicine
|
December 19, 2016
Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders
Mark Slifstein, Anissa Abi-Dargham
Biological Psychiatry
|
March 22, 2018
Is it Pre- or Postsynaptic? Imaging Striatal Dopamine Excess in Schizophrenia
Mark Slifstein, Anissa Abi-Dargham
Biological Psychiatry
|
May 31, 2023
Detecting Pharmacologically Induced Serotonin Release in Depression With Positron Emission Tomography Imaging: A New Approach
Mark Slifstein, Anissa Abi-Dargham
Methods (San Diego, Calif.)
|
August 17, 2002
Positron emission tomography: imaging and quantification of neurotransporter availability
Marc Laruelle, Mark Slifstein, Yiyun Huang
Molecular Imaging and Biology
|
December 12, 2003
Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography
Marc Laruelle, Mark Slifstein, Yiyun Huang
Handbook of Clinical Neurology
|
October 14, 2014
Molecular imaging in alcohol dependence
Shervin Ravan, Diana Martinez, Mark Slifstein, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
December 18, 2019
A positron emission tomography occupancy study of brexpiprazole at dopamine D<sub>2</sub> and D<sub>3</sub> and serotonin 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors, and serotonin reuptake transporters in subjects with schizophrenia
Ragy R Girgis, Andy Forbes, Anissa Abi-Dargham, et al.
International Review of Neurobiology
|
November 18, 2005
Neuroreceptor imaging in psychiatry: theory and applications
W Gordon Frankle, Mark Slifstein, Peter S Talbot, et al.
Page
of 14